Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morning vs Evening Enalapril/HCTZ in Hypertension (THYME)
NCT02214498Phase 4Unknown
- Sponsor
- Erasmus MC
- Start
- May 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of enalapril and hydrochlorothiazide in essential hypertension, sponsored by Erasmus MC. Primary endpoint: Average nocturnal blood pressure at 24 hours. Status: unknown.
02
Drugs
enalaprilhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02214498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214498.